memory+
memory+, licence 80006108: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Genuine Health Inc.
- NPN or DIN-HM
- 80006108
- Status
- Active licence
- Licence date
- 12 June 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Feuille(s) Extraction ratio : 50:1 Dry plant equivalent : 2000 mg Potency : 24.0 % Flavonglycosides | 40.0 mg | Not calculated |
| Ginkgo biloba Source : Feuille(s) Potency : 6.0 % Terpene lactones | Not specified | Not calculated |
Non-medicinal ingredients
Eau, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3.0 Capsule | Not specified |
Uses authorised in Canada
Helps improve memory in an aging population.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Not to be taken by children, during pregnancy, while breastfeeding, or by those on prescription medication, being treated for diabetes, or who have peptic ulcer disease unless under the recommendation of a health care practitioner. Discontinue use if you experience any symptoms of gastrointestinal upset. Consult a health care practitioner prior to use if you have any type of acute infection. Consult a health care practitioner if symptoms persist or worsen. Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended.
- Contre-indications
Do not use if you have high blood pressure, or if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as these may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80006108
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.